International Journal of Drug Policy
Volume 16, Issue 3 , Pages 171-175 , June 2005

Trends in the injection of midazolam and other drugs and needle sharing among injection drug users enrolled in the AIDSVAX B/E HIV-1 vaccine trial in Bangkok, Thailand

  • Frits Van Griensven

      Affiliations

    • Thailand Ministry of Public Health, US Centers for Disease Control and Prevention Collaboration, DDC 7 Building, Nonthaburi 11000, Thailand
    • Centers for Disease Control and Prevention, Atlanta, GA, USA
    • Corresponding Author InformationCorresponding author. Tel.: +66 25800669; fax: +66 25800712.
    • ,
  • Punnee Pitisuttithum

      Affiliations

    • Mahidol University, Bangkok, Thailand
    • ,
  • Suphak Vanichseni

      Affiliations

    • Bangkok Vaccine Evaluation Group, Bangkok, Thailand
    • ,
  • Paula Wichienkuer

      Affiliations

    • Thailand Ministry of Public Health, US Centers for Disease Control and Prevention Collaboration, DDC 7 Building, Nonthaburi 11000, Thailand
    • ,
  • Jordan W. Tappero

      Affiliations

    • Thailand Ministry of Public Health, US Centers for Disease Control and Prevention Collaboration, DDC 7 Building, Nonthaburi 11000, Thailand
    • Centers for Disease Control and Prevention, Atlanta, GA, USA
    • ,
  • Udomsak Sangkum

      Affiliations

    • Bangkok Vaccine Evaluation Group, Bangkok, Thailand
    • ,
  • Dwip Kitayaporn

      Affiliations

    • Mahidol University, Bangkok, Thailand
    • ,
  • Boonrawd Phasithiphol

      Affiliations

    • Bangkok Vaccine Evaluation Group, Bangkok, Thailand
    • ,
  • Karin Orelind

      Affiliations

    • VaxGen Inc., Brisbane, CA, USA
    • ,
  • Kachit Choopanya

      Affiliations

    • Bangkok Vaccine Evaluation Group, Bangkok, Thailand

Received 4 June 2004 ,Revised 18 February 2005 ,Accepted 21 February 2005.

References 

  1. Centers for Disease Control Prevention. Appendix C: Basic and expanded HIV postexposure prophylaxis regimens. MMWR Morbidity and Mortality Weekly Report. 2001;50(RR11):47–52
  2. Choopanya K, Des Jarlais DC, Vanichseni S, et al. HIV risk reduction in a cohort of injecting drug users in Bangkok, Thailand. Journal of Acquired Immune Deficiency Syndromes. 2004;37:1170–1179
  3. Diggle PJ, Liang K, Zeger SL. Analysis of longitudinal data. Oxford: Oxford University Press; 1994;
  4. F Hoffmann-La Roche Ltd., 1997. Dormicum (midazolam) tablets package insert. 2374056 FE 9903.1016.
  5. Konigs F. Validating population surveys for the measurement of HIV/STD prevention indicators. AIDS. 1995;9:867–873
  6. Munzar P, Yasar S, Redhi GH, Justinova Z, Goldberg SR. High rates of midazolam self-administration in squirrel monkeys. Behavioural Pharmacology. 2001;12:257–265
  7. Perera I, Lim L. Amineptine and midazolam dependence. Singapore Medical Journal. 1998;39:129–131
  8. Shore RE, Marmor M, Titus S, Des Jarlais DC. Methadone maintenance and other factors associated with intraindividual temporal trends in injection drug use. Journal Substance Abuse Treatment. 1996;13:241–248
  9. Stimson GV, Des Jarlais DC, Ball A. Drug injecting and HIV infection: global dimensions and local responses. London: UCL Press; 1998;
  10. Van Griensven F, Kaewkungwal J, Vanichseni S, et al. Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX B/E HIV vaccine efficacy trial in Bangkok, Thailand. AIDS. 2004;18:295–301
  11. The Wire, (2003). Amnesty International's Monthly Magazine. Thailand's ‘war on drugs’. http://web.amnesty.org/web/wire.nsf/May2003/Thailand (accessed 04 June 2004).
  12. Vanichseni S, Tappero JW, Pitisuttitham P, et al. Recruitment, screening and baseline epidemiologic characteristics of injection drug users enrolled in the AIDSVAX® B/E HIV vaccine trial in Bangkok Thailand: Comparison of characteristics with a preparatory cohort study. AIDS. 2004;18:1–6

PII: S0955-3959(05)00045-9

doi: 10.1016/j.drugpo.2005.02.003

International Journal of Drug Policy
Volume 16, Issue 3 , Pages 171-175 , June 2005

Article Tools

* Image Usage & Resolution